#1 Clinical Trials Search in Europe

Mycophenolate Sodium

Mycophenolate sodium, also known by the brand name Myfortic, is an immunosuppressant drug being studied in various clinical trials. These trials are exploring its use in organ transplantation, particularly kidney transplants, as well as in autoimmune conditions like lupus nephritis and Sjogren’s syndrome. Researchers are investigating its effectiveness, safety profile, and optimal dosing compared to other immunosuppressants. The trials aim to better understand how mycophenolate sodium can help prevent organ rejection and manage autoimmune diseases while minimizing side effects.

Table of Contents

What is Mycophenolate Sodium?

Mycophenolate sodium is an immunosuppressant medication used to prevent organ rejection in transplant patients and treat certain autoimmune diseases. It’s also known by its brand names Myfortic® and Mycophenolate Sodium[1][2]. This drug is an enteric-coated version of mycophenolate mofetil (MMF), which is sold under the brand name CellCept®[2]. The enteric coating helps to reduce gastrointestinal side effects that are common with MMF[2].

Medical Uses

Mycophenolate sodium is primarily used in the following medical conditions:

  • Kidney Transplantation: It’s used to prevent organ rejection in kidney transplant recipients[1][8].
  • Heart Transplantation: While primarily approved for kidney transplants, it’s also being studied for use in heart transplant patients[2].
  • Lupus Nephritis: This is a kidney inflammation caused by systemic lupus erythematosus (SLE)[1].
  • Autoimmune Uveitis: An inflammation of the middle layer of the eye caused by the immune system attacking the eye[9][10].
  • Primary Sjögren’s Syndrome: An autoimmune disorder that affects glands that produce tears and saliva[5].

How It Works

Mycophenolate sodium works by suppressing the immune system. Once in the body, it’s converted to mycophenolic acid (MPA), which inhibits an enzyme called inosine monophosphate dehydrogenase (IMPDH). This enzyme is crucial for the production of guanine nucleotides, which are essential for the growth of T and B lymphocytes (types of white blood cells). By inhibiting IMPDH, mycophenolate sodium reduces the proliferation of these lymphocytes, thereby suppressing the immune response[5].

Administration and Dosage

Mycophenolate sodium is typically taken orally in tablet form. The dosage can vary depending on the condition being treated and individual patient factors. Some common dosages include:

  • For kidney transplant patients: 720 mg twice daily[1].
  • For lupus nephritis: 720 mg twice daily[1].
  • For uveitis: 360 mg twice daily, potentially increasing to 720 mg twice daily[9][10].

It’s important to note that dosages may be adjusted based on how well you respond to the medication and any side effects you experience. Always take this medication exactly as prescribed by your doctor[1][9].

Side Effects and Tolerability

While mycophenolate sodium is generally well-tolerated, it can cause side effects. The most common side effects are gastrointestinal issues, which may include:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Indigestion

The enteric coating of mycophenolate sodium was specifically designed to reduce these gastrointestinal side effects compared to mycophenolate mofetil[2]. However, some patients may still experience these symptoms. If you experience severe or persistent gastrointestinal symptoms, contact your healthcare provider[8].

Other potential side effects include increased risk of infections due to the immunosuppressive effects of the medication. Your doctor will monitor you closely for any signs of infection[1].

Drug Interactions

Mycophenolate sodium can interact with other medications. One notable interaction is with proton pump inhibitors (PPIs), a class of drugs used to reduce stomach acid. Studies have shown that PPIs like pantoprazole can affect the absorption of mycophenolate sodium, potentially reducing its effectiveness[7]. Always inform your doctor about all medications you’re taking, including over-the-counter drugs and supplements.

Ongoing Research

Researchers continue to study mycophenolate sodium to better understand its effects and potential uses. Some areas of ongoing research include:

  • Its use in heart transplant patients[2].
  • Comparing its effectiveness and tolerability to mycophenolate mofetil in various patient populations[8].
  • Its potential use in treating autoimmune diseases like uveitis and Sjögren’s syndrome[9][5].
  • Understanding how factors like food intake affect its absorption and effectiveness[6].

These ongoing studies aim to optimize the use of mycophenolate sodium and potentially expand its applications in treating various conditions.

Aspect Details
Main Uses Prevent organ rejection in transplants (especially kidney), treat autoimmune conditions
Conditions Studied Kidney transplantation, lupus nephritis, Sjogren’s syndrome, uveitis
Dosage Range 720 mg to 1440 mg daily, typically divided into two doses
Common Side Effects Gastrointestinal issues (nausea, vomiting, diarrhea), increased risk of infections
Key Study Objectives Efficacy in preventing rejection, safety profile, optimal dosing, comparison to other immunosuppressants
Special Considerations Food effects on absorption, interactions with other medications (e.g., proton pump inhibitors)

FAQ

  • What is mycophenolate sodium used for? Mycophenolate sodium is primarily used as an immunosuppressant drug to prevent organ rejection in transplant patients, especially kidney transplant recipients. It is also being studied for use in autoimmune conditions like lupus nephritis and Sjogren's syndrome.
  • How does mycophenolate sodium work? Mycophenolate sodium works by inhibiting an enzyme called inosine monophosphate dehydrogenase (IMPDH). This blocks the production of guanosine nucleotides, which are needed for the growth of T and B lymphocytes. By suppressing these immune cells, it helps prevent organ rejection and reduce autoimmune activity.
  • What are the main side effects of mycophenolate sodium? Common side effects can include gastrointestinal issues like nausea, vomiting, and diarrhea. It may also increase the risk of infections. Some trials are specifically looking at gastrointestinal tolerability compared to other immunosuppressants.
  • How is mycophenolate sodium taken? Mycophenolate sodium is usually taken orally in tablet form, typically twice daily. The exact dosage depends on the condition being treated and other factors. Some trials are studying doses ranging from 720 mg to 1440 mg per day.
  • What are researchers hoping to learn from these clinical trials? Researchers are studying the effectiveness and safety of mycophenolate sodium compared to other immunosuppressants. They are looking at optimal dosing, its ability to prevent organ rejection, its use in autoimmune conditions, and ways to minimize side effects. Some trials are also examining how food and other medications may affect its absorption and effectiveness.

Ongoing Clinical Trials on Mycophenolate Sodium

  • Reduced Immunosuppression Therapy Trial for Elderly Kidney Transplant Recipients with End-Stage Renal Disease

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany Hungary Portugal Spain

Glossary

  • Mycophenolate sodium: An immunosuppressant drug used to prevent organ rejection in transplant patients and being studied for autoimmune conditions. It is the active form of mycophenolate mofetil.
  • Immunosuppressant: A type of drug that reduces the strength of the body's immune system, used to prevent organ rejection in transplant patients or to treat autoimmune diseases.
  • Lupus nephritis: A kidney inflammation caused by systemic lupus erythematosus (SLE), an autoimmune disease.
  • Sjogren's syndrome: An autoimmune disorder characterized by dry eyes and dry mouth, which can also affect other parts of the body.
  • Enteric-coated: A type of coating on a tablet that allows it to pass through the stomach and dissolve in the small intestine, potentially reducing stomach irritation.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Area Under the Curve (AUC): A measure of the total exposure to a drug over time, used in pharmacokinetic studies.
  • Glomerular Filtration Rate (GFR): A measure of how well the kidneys are filtering waste from the blood.
  • Uveitis: Inflammation of the uvea, the middle layer of the eye, which can cause vision problems.
  • Gastrointestinal Symptom Rating Scale (GSRS): A questionnaire used to assess the severity of gastrointestinal symptoms in patients.

References

  1. https://clinicaltrials.gov/study/NCT04645589
  2. https://clinicaltrials.gov/study/NCT00574197
  3. https://clinicaltrials.gov/study/NCT01822483
  4. https://clinicaltrials.gov/study/NCT00646737
  5. https://clinicaltrials.gov/study/NCT00542763
  6. https://clinicaltrials.gov/study/NCT00585468
  7. https://clinicaltrials.gov/study/NCT01801280
  8. https://clinicaltrials.gov/study/NCT00522548
  9. https://clinicaltrials.gov/study/NCT01261169
  10. https://clinicaltrials.gov/study/NCT01092533